# Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas

> **NCT00276640** · NA · COMPLETED · sponsor: **Societe Internationale d'Oncologie Pediatrique** · enrollment: 3417 (actual)

## Conditions studied

- Primary Central Nervous System Neoplasms

## Interventions

- **DRUG:** vincristine, carboplatin
- **DRUG:** vincristine, carboplatin, etoposide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00276640
- **Lead sponsor:** Societe Internationale d'Oncologie Pediatrique
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-01
- **Primary completion:** 2015-12-31
- **Final completion:** 2017-05-31
- **Target enrollment:** 3417 (ACTUAL)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00276640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00276640, "Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00276640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*